HyperSpectral, which is known as the world’s first AI-based spectral intelligence company, has closed a $7 million Series A-2 capital raise. This funding round is significant as it will serve to accelerate the company’s development efforts, expand its partnerships, and position HyperSpectral for an anticipated Series B funding round slated for 2026. The funding was co-led by RRE Ventures and Kibo Ventures, with ongoing support from existing investors who believe in the company’s vision. Additionally, new investors have joined the ranks, including Avalanche Thinking.
A noteworthy addition to HyperSpectral’s leadership team is Dr. Vincent D. (Chuck) Mattera, the Chairman and CEO of Avalanche Thinking. Dr. Mattera, who previously served as the Chair and CEO of Coherent Corp—a publicly traded company on the NYSE—will join HyperSpectral’s Board as Chairman. His extensive experience in governance within the photonics and industrial manufacturing sectors will enhance the company’s strategic leadership, reinforcing its readiness for significant growth ahead of its next financing round.
Since emerging from stealth mode in 2024, HyperSpectral has generated considerable momentum and recognition within the industry. In the last 12 months, its innovative SpecAI platform has garnered acclaim as a Gartner Emerging Tech Innovator in the field of Computer Vision Applications. Furthermore, the platform was named a finalist for the 2025 R&D 100 awards, which honor the year’s most innovative technologies. The company also received the prestigious SPIE Prism Award, underscoring its commitment to advancing technology.
How the funding will be used: The funds raised will play a crucial role in enhancing HyperSpectral’s technology platform, allowing it to develop further in preparation for commercial scaling. This financial support will also help strengthen the company’s position with key customers and partners, ensuring that it can continue to lead and innovate in the spectral intelligence space.
KEY QUOTES:
“This round underscores investor conviction in our progress and potential. We are aiming to scale rapidly into the broad biotech, industrial, and defense markets and are excited to have Chuck Mattera join our Board. Chuck’s leadership and experience will be instrumental as we penetrate these markets in the U.S. and expand globally. In its initial deployments, HyperSpectral’s platform combines chemical physics and materials-science-based spectroscopy with advanced AI algorithms trained on proprietary data sets, enabling the rapid, non-invasive detection of bacteriological pathogens in minutes and without specialized lab preparation. This results in immediate breakthroughs in lower costs, faster cycle times, higher quality and better reliability.”
CEO Matt Theurer
“Spectral Intelligence can change the way industries organize to leverage AI to help make decisions and control processes by providing data instantly, with differentiated advantages including reliability and scale. HyperSpectral has the vision, team, and technology to lead this transformation, and I am pleased to have been selected to join the Board and for Avalanche Thinking to support the company’s exciting growth aspirations.”
Dr. Chuck Mattera
